The Colombian Association of Internal Medicine and the Colombian Association of Neurology agree to support Khiron’s development of medical cannabis education, research and professional programs for nearly 3,000 doctors...

Under Mr. Murphy’s guidance, Khiron becomes only medical cannabis producer in Colombiawith DEA-level security protocols TORONTO, May 31, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN), a Canadian...

Khiron Receives INVIMA Approval to Commercialize CBD Products for Colombian Domestic Sale and Export First Fully Licensed Company in Colombia to Receive INVIMA Approval TORONTO, May 30, 2018 /CNW/ – Khiron life Sciences...

TORONTO, May 29, 2018 /CNW/ – Khiron life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today the Company is...

This is a copy of the May 27th edition of our weekly Newsletter, which we have been publishing since October, 2015. Friends, This mission of New Cannabis Ventures has...

Khiron to Commence Trading on TSX Venture Exchange — First Canadian Cannabis Company with Core Operations in Colombia to List on Any Exchange Globally — — Khiron to Host...

This is a copy of the May 13th edition of our weekly Newsletter, which we have been publishing since October, 2015. Friends, Four years ago, cannabis stocks were for...